Hodis HN - Search Results

1

Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.

Arellanes IC, Choe N, Solomon V, He X, Kavin B, Martinez AE, Kono N, Buennagel DP, Hazra N, Kim G, D'Orazio LM, McCleary C, Sagare A, Zlokovic BV, Hodis HN, Mack WJ, Chui HC, Harrington MG, Braskie MN, Schneider LS, Yassine HN. Arellanes IC, et al. Among authors: hodis hn. EBioMedicine. 2020 Sep;59:102883. doi: 10.1016/j.ebiom.2020.102883. Epub 2020 Jul 17. EBioMedicine. 2020. PMID: 32690472 Free PMC article. Clinical Trial.

2

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

Hodis HN, Mack WJ. Hodis HN, et al. Curr Opin Lipidol. 1995 Aug;6(4):209-14. doi: 10.1097/00041433-199508000-00004. Curr Opin Lipidol. 1995. PMID: 7670749 Review.

3

Prevention of coronary atherosclerosis.

Hodis HN, Cashin-Hemphill L, Mack WJ. Hodis HN, et al. Heart Dis Stroke. 1994 Jul-Aug;3(4):182-7. Heart Dis Stroke. 1994. PMID: 7921660 Review. No abstract available.

4

Risk factor assessment, treatment strategy and prevention of coronary artery disease: the need for a more rational approach.

Hodis HN, Mack WJ. Hodis HN, et al. J Intern Med. 1994 Aug;236(2):111-3. doi: 10.1111/j.1365-2796.1994.tb01272.x. J Intern Med. 1994. PMID: 8046309 No abstract available.

5

Carotid intima-media thickness as a surrogate end point for coronary artery disease.

Hodis HN, Mack WJ, Barth J. Hodis HN, et al. Circulation. 1996 Nov 1;94(9):2311-2. Circulation. 1996. PMID: 8901695 No abstract available.

6

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.

Mack WJ, Krauss RM, Hodis HN. Mack WJ, et al. Among authors: hodis hn. Arterioscler Thromb Vasc Biol. 1996 May;16(5):697-704. doi: 10.1161/01.atv.16.5.697. Arterioscler Thromb Vasc Biol. 1996. PMID: 8963728 Clinical Trial.

7

Efficacy of interventions designed to inhibit the progression of coronary atherosclerosis.

Mack WJ, Hodis HN. Mack WJ, et al. Among authors: hodis hn. Diabetes Res Clin Pract. 1996 Feb;30 Suppl:37-53. doi: 10.1016/s0168-8227(96)80037-4. Diabetes Res Clin Pract. 1996. PMID: 8964192 Review.

8

Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.

Markus RA, Mack WJ, Azen SP, Hodis HN. Markus RA, et al. Among authors: hodis hn. Am J Clin Nutr. 1997 Apr;65(4):1000-4. doi: 10.1093/ajcn/65.4.1000. Am J Clin Nutr. 1997. PMID: 9094885 Clinical Trial.

9

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.

Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. Alaupovic P, et al. Among authors: hodis hn. Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):715-22. doi: 10.1161/01.atv.17.4.715. Arterioscler Thromb Vasc Biol. 1997. PMID: 9108785 Clinical Trial.

10

A comparison of quantitative computerized and human panel coronary endpoint measures: implications for the design of angiographic trials.

Mack WJ, Azen SP, Dunn M, Hodis HN. Mack WJ, et al. Among authors: hodis hn. Control Clin Trials. 1997 Apr;18(2):168-79. doi: 10.1016/s0197-2456(96)00181-x. Control Clin Trials. 1997. PMID: 9129860 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page